Ascletis trial shows drug candidate ASC47 boosts semaglutide weight loss effect
- Posted on September 22, 2025
- By South China Morning Post
- 1 Views
Ascletis trial shows drug candidate ASC47 boosts semaglutide weight loss effect
Chinese biotech firm is among dozens of mainland drug makers seeking to compete in the global market for diabetes and weight-loss drugs.
